Last reviewed · How we verify
infarction
Approved treatments
- Technetium Tc 99M Sestamibi · Cyclomedica
Technetium Tc 99m Sestamibi accumulates in viable myocardial tissue similar to thallous chloride TI-201, with possible mitochondrial retention. - Technetium Tc 99M Sestamibi · Cyclomedica
Technetium Tc 99m Sestamibi accumulates in viable myocardial tissue similar to thallous chloride TI-201, with possible mitochondrial retention. - Flyrcado · Ge Hlthcare
Flyrcado emits radiation to create detailed images of the heart, allowing for the diagnosis of coronary artery disease and other heart conditions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- infarction patent landscape — cliff calendar, originator estates, attackable patents
- infarction treatment landscape brief
- infarction treatment updates RSS
Frequently asked questions about infarction
What drugs treat infarction?
Tracked treatments include Technetium Tc 99M Sestamibi, Flyrcado.
What is the treatment for infarction?
Standard treatment for infarction includes Technetium Tc 99M Sestamibi, Flyrcado. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: infarction patent cliff · infarction CI report
- Treatment: Technetium Tc 99M Sestamibi · Cyclomedica
- Treatment: Technetium Tc 99M Sestamibi · Cyclomedica
- Treatment: Flyrcado · Ge Hlthcare
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing